Results 141 to 150 of about 4,164 (194)

Assessing cortical bone changes with Romosozumab after one year: Insights from an exploratory HR-pQCT study. [PDF]

Bone Rep
Zanchetta MB, Gonzalez-Pernas M, Jerkovich F, Pingel J, Schwartz N, Erdociain L, Zanchetta JR.   +6 more
europepmc   +1 more source

Glucocorticoid-Induced Osteoporosis: Pathogenesis, the Impact of Different Administration Routes on Bone Mineral Density, and Fracture Risk and Treatment Options-A Narrative Review. [PDF]

J Clin Med
Kapszewicz M, Michalska-Kasiczak M, Sewerynek E.   +2 more
europepmc   +1 more source

Socioeconomic vulnerability and osteoporosis treatment disparities during COVID-19 lockdown among U.S. medicare enrollees who initiated romosozumab. [PDF]

Osteoporos Int
Liu Y, Arora T, Zhang J, Sen B, Becker D, Sun R, Yun H, Saag KG, Curtis JR.   +8 more
europepmc   +1 more source

Effects of romosozumab and teriparatide on hip bone using 3D-SHAPER in postmenopausal women with osteoporosis. [PDF]

JBMR Plus
Lewiecki EM, Betah D, Humbert L, Libanati C, Oates M, Shi Y, Winzenrieth R, Ferrari S, Omura F.   +8 more
europepmc   +1 more source

Approach to osteoporosis diagnosis and fracture risk management in primary care. [PDF]

Can Fam Physician
Garg D, MacLaren J, Stapleton C, Bhella V, Payne J, Billington E.   +5 more
europepmc   +1 more source

Management of male osteoporosis in primary care: clinical approach and pharmacotherapy. [PDF]

Singapore Med J
Poh SXJ, Choong SD, Gani LU, Chua ALA.
europepmc   +1 more source

Early Postmenopausal Fragility Fractures and Elevated IgE: Two Cases Suggesting Hyper-IgE Syndrome and a Novel Adverse Reaction to Romosozumab. [PDF]

Calcif Tissue Int
Collins L, Ebeling PR.
europepmc   +1 more source

Effect of genetically proxied plasma sclerostin levels on the risk of ischemic stroke: A drug-target Mendelian randomization study. [PDF]

Medicine (Baltimore)
Lee WV, Oh JM, Kim IW.
europepmc   +1 more source

Treatment With Romosozumab In Progressive Pseudorheumatoid Dysplasia. [PDF]

JCEM Case Rep
Bisceglia N, Scarano E, Piazza A, Gambineri A, Pagotto U, Zavatta G.   +5 more
europepmc   +1 more source

Sclerostin in Vascular Calcification: Hypoxia-Driven Regulation and Therapeutic Modulation by Natural Products. [PDF]

Curr Atheroscler Rep
Yeon S, Seto SW, Bhuyan JD, Chang D, Li CG, Low M.   +5 more
europepmc   +1 more source